sc 58125 has been researched along with Adjuvant Arthritis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GD; Burton, EG; Cogburn, JN; Collins, JT; Garland, DJ; Gregory, SA; Huang, HC; Isakson, PC; Koboldt, CM; Li, JJ | 1 |
Anderson, GD; Collins, JT; Gregory, SA; Koboldt, CM; Li, JJ; Norton, MB; Perkins, WE; Reinhard, EJ; Reitz, DB; Seibert, K | 1 |
Bertenshaw, SR; Burton, EG; Carter, JS; Cogburn, JN; Collins, PW; Docter, S; Graneto, MJ; Gregory, SA; Isakson, PC; Koboldt, CM; Lee, LF; Malecha, JW; Miyashiro, JM; Penning, TD; Perkins, WE; Rogers, RS; Rogier, DJ; Seibert, K; Talley, JJ; Veenhuizen, AW; Yu, SS; Zhang, YY | 1 |
Gregory, S; Hauser, S; Isakson, P; Leahy, K; Masferrer, J; Olson, G; Perkins, W; Seibert, K; Zhang, Y | 1 |
Anderson, G; Bremer, M; Gierse, J; Gregory, S; Hauser, S; Koboldt, C; Leahy, K; Masferrer, J; Seibert, K; Zhang, Y | 1 |
Anderson, GD; Bremer, ME; Gregory, SA; Hauser, SD; Isakson, PC; McGarity, KL | 1 |
1 review(s) available for sc 58125 and Adjuvant Arthritis
Article | Year |
---|---|
Mediation of inflammation by cyclooxygenase-2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Inflammation; Isoenzymes; Prostaglandin-Endoperoxide Synthases; Pyrazoles | 1995 |
5 other study(ies) available for sc 58125 and Adjuvant Arthritis
Article | Year |
---|---|
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase Inhibitors; Cyclopentanes; Dose-Response Relationship, Drug; Edema; Indomethacin; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Sulfonamides; Sulfones | 1995 |
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Cyclooxygenase Inhibitors; Cyclopentanes; Mice; Rats | 1994 |
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Molecular Structure; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides | 1997 |
Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase Inhibitors; Gene Expression; Indomethacin; Inflammation; Isoenzymes; Organ Specificity; Prostaglandin-Endoperoxide Synthases; Pyrazoles; RNA, Messenger; Rodentia | 1995 |
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.
Topics: Animals; Arthritis, Experimental; Base Sequence; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; DNA Primers; Gene Expression; Gene Expression Regulation, Enzymologic; Indomethacin; Inflammation; Interleukin-6; Isoenzymes; Joints; Male; Molecular Sequence Data; Polymerase Chain Reaction; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 1996 |